FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
14 letters match. Newest first.
-
DevicesNext Medical Products Company, LLC
FDA warns Next Medical Products that its ultrasound gels were contaminated and made without required quality controls or clearance.
High risk -
DevicesLion Street Medical, d/b/a Pensar Medical LLC
FDA warns Pensar Medical over unreported wound-therapy injuries and missing device reporting procedures.
High risk -
DevicesSpecialty Health Products CO, LLC
Specialty Health Products was cited for quality-system, unapproved marketing, and listing violations for its Hydro-San and Aqua Cleanse colonic irrigation devices.
High risk -
DevicesNipro Renal Solutions USA, Corporation
Nipro Renal Solutions USA released hemodialysis dialysate lots with out-of-spec endotoxin (bacterial toxin) and had widespread quality-system failures, FDA says.
High risk -
DevicesKoven Technologies, Inc.
FDA warns Koven Technologies that its Bidop 3 Doppler was labeled for fetal use without clearance and had quality system violations.
High risk -
DevicesZIIP, Inc.
FDA warns ZIIP over quality-system violations and unapproved marketing of HALO 2.0, DOT, and gels.
High risk -
DevicesBMC Medical Co., Ltd.
BMC Medical’s G3X APAP devices were misbranded/adulterated after significant changes without a new 510(k) and an unreported firmware fix.
High risk -
DevicesUnetixs Vascular, Inc.
Unetixs Vascular marketed modified ROODRA and 2CP vascular diagnostic devices without required FDA clearance.
High risk -
DevicesIsoTis OrthoBiologics, Inc.
IsoTis OrthoBiologics in Irvine, CA failed to properly fix and assess possible particulate contamination in its Accell bone filler devices, FDA says.
High risk -
DevicesHong Qiangxing Shenzhen Electronics Limited
FDA warned Hong Qiangxing Shenzhen Electronics after an inspection found quality-system violations in TENS, muscle stimulator, and blood pressure monitor manufacturing.
Medium -
DrugsRalph A. DeFronzo, M.D.
FDA warns Dr. Ralph A. DeFronzo for enrolling ineligible subjects and failing to promptly report study changes to the IRB.
High risk -
DevicesUscom Kft
Uscom Kft marketed SpiroSonic AIR spirometer in the U.S. without FDA clearance and had multiple quality system failures at its Budapest plant.
High risk -
DevicesSpectra Therapy, LLC
FDA warns Spectra Therapy over LASERwrap infrared lamp device quality-system violations and unapproved disease-treatment claims.
High risk -
DevicesCellEra LLC
CellEra LLC's sterile silver wound dressings have repeated quality-system violations and uncleared labeling claims, FDA says.
High risk